GlassScriptPhysician profile
Paul C Armstrong
NPI 1871574053
$947.28
in general payments reported to CMS, 2019-2025
15 companies · $57.80 in 2025
The $57.80 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $544 · 2021: $15.35 · 2022: $55.58 · 2023: $30.09 · 2024: $78.45 · 2025: $57.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $368.69 | 2020-2024 | Cook Celect |
| Portola Pharmaceuticals, LLC | $125.93 | 2019-2020 | |
| Olympus America INC. | $77.59 | 2019-2020 | |
| Heron Therapeutics, INC. | $75.85 | 2022-2023 | Zynrelef |
| Smith+Nephew, INC. | $68.13 | 2020-2025 | Grafix Pl, Stravix, Oasis |
| Takeda Pharmaceuticals U.S.A., INC. | $32.84 | 2020-2021 | |
| Shire North American Group INC | $31.72 | 2019 | |
| Lifenet Health | $27.10 | 2023-2025 | Theragenesis Wound Matrix |
| Lemaitre Vascular, INC. | $25.71 | 2019-2020 | |
| Integra Lifesciences Corporation | $24.42 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $19.95 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Boston Scientific Corporation | $19.09 | 2019 | |
| Medtronic Vascular, INC. | $17.13 | 2020 | |
| Aroa Biosurgery Incorporated | $16.95 | 2024 | |
| Kci USA, INC. | $16.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.